Cargando…

Metformin Treatment May Increase Omentin-1 Levels in Women With Polycystic Ovary Syndrome

OBJECTIVE: Polycystic ovary syndrome (PCOS) is associated with the metabolic syndrome. Decreased omentin-1 levels are associated with obesity and diabetes. To study the effects of metformin treatment on omentin-1 levels in PCOS subjects and effects of omentin-1 on in vitro migration and angiogenesis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Bee K., Adya, Raghu, Farhatullah, Syed, Chen, Jing, Lehnert, Hendrik, Randeva, Harpal S.
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2010
Materias:	Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992762/ https://www.ncbi.nlm.nih.gov/pubmed/20852028 http://dx.doi.org/10.2337/db10-0124

Ejemplares similares

Fibroblast Growth Factor 21 (FGF21) in Human Cerebrospinal Fluid: Relationship With Plasma FGF21 and Body Adiposity
por: Tan, Bee K., et al.
Publicado: (2011)

Insulin and Metformin Regulate Circulating and Adipose Tissue Chemerin
por: Tan, Bee K., et al.
Publicado: (2009)

Ex Vivo and In Vivo Regulation of Lipocalin-2, a Novel Adipokine, by Insulin
por: Tan, Bee K., et al.
Publicado: (2009)

Differential Effects of Leptin and Adiponectin in Endothelial Angiogenesis
por: Adya, Raghu, et al.
Publicado: (2015)

Capability, Opportunity, and Motivation—Identifying Constructs for Increasing Physical Activity Behaviours in Women with Polycystic Ovary Syndrome (PCOS)
por: Kite, Chris, et al.
Publicado: (2023)

Study on the Effect of Berberine, Myoinositol, and Metformin in Women with Polycystic Ovary Syndrome: A Prospective Randomised Study
por: Mishra, Neha, et al.
Publicado: (2022)

Expression of Serum Omentin, CTRP9, and Vaspin in Patients with Polycystic Ovary Syndrome
por: Wang, Yuhong, et al.
Publicado: (2022)

Relationship Between Cerebrospinal Fluid Visfatin (PBEF/Nampt) Levels and Adiposity in Humans
por: Hallschmid, Manfred, et al.
Publicado: (2009)

Why are Women With Polycystic Ovary Syndrome at Increased Risk of Depression? Exploring the Etiological Maze
por: Gnawali, Anupa, et al.
Publicado: (2021)

Assessment of serum chemerin, vaspin and omentin-1 levels in patients with polycystic ovary syndrome
por: Guvenc, Yesim, et al.
Publicado: (2016)

Frequency of Subclinical Hypothyroidism in Women With Polycystic Ovary Syndrome
por: Raj, Deepak, et al.
Publicado: (2021)

Metformin increases pressure pain threshold in lean women with polycystic ovary syndrome
por: Kiałka, Marta, et al.
Publicado: (2016)

Risk of Gynecological Cancers in Women With Polycystic Ovary Syndrome and the Pathophysiology of Association
por: Shetty, Chaitra, et al.
Publicado: (2023)

Comparison of Clinical, Metabolic and Hormonal Effects of Metformin Versus Combined Therapy of Metformin With Myoinositol Plus D-Chiro-Inositol in Women With Polycystic Ovary Syndrome (PCOS): A Randomized Controlled Trial
por: Bahadur, Anupama, et al.
Publicado: (2021)

Comparison of Serum Vitamin B12 Levels Among Drug-Naïve and Metformin-Treated Patients With Polycystic Ovary Syndrome
por: Kamrul-Hasan, ABM, et al.
Publicado: (2022)

Effects of Metformin on Symptoms of Polycystic Ovarian Syndrome Among Women of Reproductive Age
por: Artani, Moiz, et al.
Publicado: (2018)

Sleep Disruption and Depression, Stress and Anxiety Levels in Women With Polycystic Ovary Syndrome (PCOS) During the Lockdown Measures for COVID-19 in the UK
por: Kite, Chris, et al.
Publicado: (2021)

The prevalence of obstructive sleep apnoea in women with polycystic ovary syndrome: a systematic review and meta-analysis
por: Kahal, Hassan, et al.
Publicado: (2019)

Influence of Subclinical Hypothyroidism on Women With Polycystic Ovary Syndrome: A Literature Review
por: Peddemul, Aishwarya, et al.
Publicado: (2022)

Women With Polycystic Ovary Syndrome: A Review of Susceptibility to Type 2 Diabetes
por: Layacha, Sakshi Y, et al.
Publicado: (2023)

Effect of Metformin on Serum Ferritin Level in Women with Polycystic Ovary Syndrome
por: Behradmanesh, S, et al.
Publicado: (2011)

Clinical outcome of various metformin treatments for women with polycystic ovary syndrome
por: Matsuzaki, Toshiya, et al.
Publicado: (2017)

Impaired Prolactin-Lowering Effects of Metformin in Women with Polycystic Ovary Syndrome
por: Krysiak, Robert, et al.
Publicado: (2023)

New Therapeutic Approaches in Obesity and Metabolic Syndrome Associated with Polycystic Ovary Syndrome
por: Saleem, Fatima, et al.
Publicado: (2017)

Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis
por: Kite, Chris, et al.
Publicado: (2019)

Müllerian Duct Anomalies and Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome
por: Yang, Min, et al.
Publicado: (2023)

Time to Load Up–Resistance Training Can Improve the Health of Women with Polycystic Ovary Syndrome (PCOS): A Scoping Review
por: Kite, Chris, et al.
Publicado: (2022)

Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic
por: Kyrou, Ioannis, et al.
Publicado: (2020)

The relationship between obstructive sleep apnoea and quality of life in women with polycystic ovary syndrome: a cross-sectional study
por: Kahal, Hassan, et al.
Publicado: (2020)

Uncertainty, Anxiety and Isolation: Experiencing the COVID-19 Pandemic and Lockdown as a Woman with Polycystic Ovary Syndrome (PCOS)
por: Atkinson, Lou, et al.
Publicado: (2021)

Reduced circulating levels of chemokine CXCL14 in adolescent girls with polycystic ovary syndrome: normalization after insulin sensitization
por: García-Beltran, Cristina, et al.
Publicado: (2020)

Postprandial Administration of Intranasal Insulin Intensifies Satiety and Reduces Intake of Palatable Snacks in Women
por: Hallschmid, Manfred, et al.
Publicado: (2012)

Novel Insights into the Cardio-Protective Effects of FGF21 in Lean and Obese Rat Hearts
por: Patel, Vanlata, et al.
Publicado: (2014)

Chemerin induces endothelial cell inflammation: activation of nuclear factor-kappa beta and monocyte-endothelial adhesion
por: Dimitriadis, Georgios K., et al.
Publicado: (2018)

Metformin Therapy Decreases Hyperandrogenism and Ovarian Volume in Women with Polycystic Ovary Syndrome
por: Farimani Sanoee, Marzieh, et al.
Publicado: (2011)

Thyroid Status During Pregnancy in Women With Polycystic Ovary Syndrome and the Effect of Metformin
por: Trouva, Anastasia, et al.
Publicado: (2022)

Association of Plasma Omentin-1 Levels With Diabetes and Its Complications
por: Eimal Latif, Abdul Habib, et al.
Publicado: (2021)

Cardiometabolic aspects of polycystic ovarian syndrome
por: Cho, Li Wei, et al.
Publicado: (2007)

The Effect of Insulin Resistance on Ovulation Induction With Clomiphene Citrate in Non-polycystic Ovary Syndrome (PCOS) Women
por: Karnatak, Ruchi, et al.
Publicado: (2022)

Type 2 Diabetes Mellitus in Patients With Polycystic Ovary Syndrome
por: Agrawal, Anjali, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nc22rgcg2ucnkgfg9n54jpif15